Next-generation IV infusion pumps market seen reaching $6.3B by 2033

Persistence Market Research says the global next-generation IV infusion pumps market will grow from $3.6 billion in 2026 to $6.3 billion by 2033, driven by demand for safer, smarter medication delivery. Hospitals, North America and smart infusion pumps are leading the market as healthcare systems adopt more connected devices and digital workflows.

Why it matters: - Next-generation IV infusion pumps are becoming central to safer medication delivery in hospitals and other care settings. - The market reflects broader healthcare spending on digital tools that can reduce medication errors, improve workflow efficiency and support connected patient care. - Demand is rising as providers look for devices that combine precision dosing, real-time monitoring and wireless connectivity.

What happened: - Persistence Market Research estimates the global next-generation IV infusion pumps market at US$ 3.6 billion in 2026. - The market is projected to reach US$ 6.3 billion by 2033. - The forecast implies a compound annual growth rate of 8.2% from 2026 to 2033. - The release was issued from Brenford, London, United Kingdom, on July 14, 2026.

The details: - Smart infusion pumps are the leading product segment because of automated drug libraries, dose error reduction systems and connectivity features. - Hospitals account for the largest end-user share because of heavy use in intensive care, oncology, surgery and emergency care. - North America leads regional demand due to advanced healthcare infrastructure, strong technology adoption and supportive regulation. - Asia Pacific is expected to post substantial growth as healthcare infrastructure improves, spending rises and hospital networks expand. - The market also includes volumetric infusion pumps, syringe infusion pumps, ambulatory infusion pumps and specialty infusion pumps. - The report says rising prevalence of chronic diseases and expanding healthcare infrastructure are supporting demand. - The report says home healthcare and outpatient treatment are creating opportunities for portable infusion systems. - The report says digital healthcare investments are accelerating innovation and long-term market growth. - The report lists Baxter International, Becton, Dickinson and Company, ICU Medical, Fresenius Kabi, B. Braun Melsungen, Smiths Medical, Terumo, Nipro, Moog and Medtronic among key players. - The company offered a free sample report at More information. - The company also offered report customization at Customize this report and full access at Buy the full report. - The release included social media links for LinkedIn, Instagram, Facebook, YouTube and X.

Between the lines: - The market outlook points to a shift away from conventional infusion systems toward connected platforms that can support safer dosing and tighter hospital oversight. - High acquisition costs, software integration, maintenance and cybersecurity requirements can slow adoption, especially for smaller hospitals. - Training, regulatory compliance and technical support add to implementation complexity, which may temper growth in cost-sensitive markets.

What's next: - Adoption is likely to keep expanding as hospitals continue digital transformation and replace older infusion systems. - North America is expected to remain the largest market, while Asia Pacific should deliver the fastest growth among major regions. - Competitive pressure is likely to intensify as manufacturers push smarter devices with stronger software and connectivity features.

The bottom line: - Smart infusion pumps are moving from upgrade items to core hospital infrastructure, and the market is on track for steady double-digit-dollar expansion over the next several years.